t he hydrophobic surfactant protein C (SP-C) is synthesized from the 191 or 197-amino-acid precursor SP-C (proSP-C), which is encoded by SFTPC on human chromosome 8p21.3. ProSP-C is an integral membrane protein that contains four regions: a short cytoplasmic N-terminal domain (residues 1-23), a mature SP-C region (residues 24-58) mainly composed of a transmembrane domain (residues 33-58), a non-BRICHOS region (residues 59-89), and a BRICHOS domain (residues 90-197) (1) . ProSP-C undergoes palmitoylation and a series of proteolytic C-and N-terminal cleavages to yield a 3.7-kDa mature peptide within subcellular compartments of the endoplasmic reticulum (ER), multivesicular bodies, lamellar bodies (LBs), and others (2) . Mature SP-C is exclusively produced by type II alveolar epithelial cells (AECs), packaged into LBs, which are a subclass of lysosomal-like organelles, and subsequently secreted to the alveolar surface. Meanwhile, phospholipids and proteins are endocytosed from the alveolar surface into early endosomes and routed back either to lysosomes for degradation or LBs for recycling (3) .
Interstitial lung disease (ILD) in infants and children represents a heterogeneous group of respiratory disorders that are mostly chronic and associated with higher morbidity and mortality than those reported in adults (4) (5) (6) . SP-C is critical in reducing alveolar surface tension at the air/liquid interface to prevent alveolar collapse at the end of expiration. Since the first report of an infant and mother with ILD due to a mutation in the SFTPC gene (4), several additional mutations have been identified in ILD patients that were associated with abnormal expression of SP-C (7, 8) . The great majority of SFTPC mutations are located in the BRICHOS domain, and associated with chronic accumulation of misfolded proSP-C (9, 10) . In contrast, in vitro studies have shown that mutations located in the non-BRICHOS region, such as proSP-C I73T , misdirected proSP-C to the plasma membrane, leading to the accumulation of abnormally processed isoforms (11) . Thus, mutations involving different domains of proSP-C may represent different pathogeneses of ILD. Although several mutations located within the mature domain of SFTPC have been recognized (7, 8, 12) , the pathway and mechanism of such mutations remain unclear.
In the present study, we describe a novel heterozygous SFTPC mutation associated with ILD in a young Japanese girl. Lung biopsy samples performed using transmission electron microscopy (TEM) revealed abnormal subcellular organelles. We also investigated whether the subcellular localization of novel proSP-C L55F was altered in A549 cells.
RESULTS

Case Summary
The patient was a young girl who had been delivered at full-term to nonconsanguineous parents without any apparent perinatal diseases. She presented with poor feeding at 2 mo of age and exhibited a failure to thrive. She was hospitalized at the age of 5 mo due to cough and tachypnea. High-resolution computed tomography at the age of 5 mo showed bilateral ground glass opacities and minimal reticulation (Figure 1a) . Histopathological evaluation of her lung tissue by open-lung biopsy revealed type II AEC hyperplasia and alveolar interstitial fibrosis with obvious inflammation (Figure 1d ) as compared with a control (Figure  1c ). According to clinical features, biochemical indicators, and radiographic and pathological findings, she was given a diagnosis of ILD. She was treated with methylprednisolone pulse therapy followed by oral prednisolone in addition to cyclosporine and azathioprine. Due to her persistently elevated supplementary oxygen requirement, the patient required conventional mechanical ventilation and hydroxychloroquine was added to her regimen. These treatments were associated with a slowing of her disease progression, and she was discharged at 2 y of age with home oxygen therapy. At the age of 10 y, her pulmonary function began to deteriorate rapidly. She successfully underwent livingdonor right single-lobe lung transplantation from her mother soon afterwards (13) . Three months after transplantation, highresolution computed tomography demonstrated a well-inflated lung allograft without obvious atelectasis (Figure 1b) .
SFTPC Genetic Analysis
Polymerase chain reaction (PCR) followed by direct sequencing of SFTPC, SFTPB, and ATP-binding cassette subfamily A, member 3 (ABCA3) were performed, and three heterozygous substitutions at bases c.163, c.413, and c.557 were detected in SFTPC (Supplementary Figure S1 online) . The c.163C>T in exon 2 located at codon 55 in the mature transmembrane domain resulted in a leucine to phenylalanine substitution (p.L55F). Neither 61 healthy Japanese volunteers, nor the patient's parents, carried this c.163C>T mutation. The patient's mother and several volunteers also possessed substitutions of c.413C>A and c.557G>A, which have been described as common coding SNPs in previous studies (14) . Paternal gene sequences were identical to those of healthy control volunteers. Congo red is a well-known marker for β-sheet amyloid aggregates. A common feature seen in BRICHOS domain mutations of proSP-C is a high tendency to misfold and form Congo red-positive aggregates (15, 16) . However, we did not detect any amyloid fibrils as identified by Congo red-positivity as green birefringent materials in the explanted lung tissue of the patient (Supplementary Figure S2g ,h online).
TEM of Lung Tissue
Patient lung tissue samples were examined by TEM to characterize the alterations in subcellular organelles related to ILD. Smaller, denser, and abnormally shaped LBs were observed in type II AECs as 0.5 μm organelles (Figure 2g,h) , which was in contrast to normal LBs having regular concentric "onion skin" lamellae and a diameter of 1-2 μm (Figure 2e,f) .
Processing of ProSP-C L55F
To identify potential processing differences between proSP-C L55F and previously reported mutations, we analyzed proSP-C I73T (17) and proSP-C A116D (18) in the non-BRICHOS and BRICHOS domains of proSP-C, respectively. Semiquantitative PCR showed that A549 cells stably expressing green fluorescent protein (GFP)-tagged proSP-C isoforms expressed comparable levels of proSP-C mRNA (data not shown). Lysates of A549 cells stably expressing GFP-tagged proSP-C isoforms were also analyzed by western blotting using anti-GFP to assess relative protein expression among proSP-C As shown in Figure 3 , a 27 kDa product was expressed in cells transfected with the pAcGFP-C 1 vector alone. We observed doublet bands for proSP-C WT and proSP-C L55F that likely corresponded to the primary translation product of the fusion protein (48 kDa) and its known palmitoylated isoform (50 kDa) (19) .
ProSP-C L55F yielded bands similar to those of proSP-C WT for the primary translation product of the fusion protein (48 kDa). Two lower molecular weight intermediates were observed at a reduced expression level, and the lowest processing intermediate , which was reported to localize at the plasma membrane, proSP-C L55F also demonstrated signs of partially trafficking toward the plasma membrane (Figure 4a) . Increased plasma membrane localization was observed for proSP-C L55F as compared with proSP-C WT at low magnification (Supplementary Figure S3 online WT and mutant proSP-C when we analyzed colocalization with ER-Tracker-Red (data not shown).
Altered Subcellular Organelles in ProSP-C L55F
To further characterize the structure of subcellular organelles, A549 cells transfected with either proSP-C WT or mutant proSP-C isoforms were evaluated by TEM. , and proSP-C A116D . Significant differences were indicated by asterisks. *P < 0.05, **P < 0.001. Liu et al.
At the ultrastructural level, nontransfected A549 cells contained various cellular components, such as early endosomes and late endosomes, within the cytoplasm (data not shown). Cells transfected with proSP-C WT showed an increased number of these organelles, which featured regular "onion skin" electron-dense and concentric lamellae with phospholipid membranes (Figure 5a,b) . Numerous disorganized lysosomallike organelles with a double membrane (white arrows) and tightly packed electron-dense dark bodies (black arrow) were observed in A549 cells stably expressing proSP-C L55F or proSP-C
I73T
. A549 cells transfected with proSP-C A116D displayed several lysosomal-like organelles with irregularly arranged and eccentrically packed lamellae ( Figure 5) .
DISCUSSION
In the present study, we described the radiological findings and histopathological and ultrastructural characteristics of a child associated with ILD at initial diagnosis. A novel mutation in one SFTPC allele (c.163C>T) in the region encoding the mature peptide of proSP-C was identified in the infant, who eventually required lung transplantation due to chronic respiratory symptoms. This mutation was not detected in her parents, healthy control volunteers, or the literature, nor has it been listed in large publicly available databases, such as the 1000 Genomes Project (http://browser.1000genomes.org/index. html), or Exome Variant Server (http://evs.gs.washington.edu/ EVS/), suggesting that it was a de novo variant.
The clinical presentations of ILD depending on patient age and outcome in infants and children have been associated with disorders of SP-C, SP-B, and ABCA3 expression. According to previous reports, recessive SP-B gene mutations were often found as a cause of lethal respiratory failure in the newborn period; most infants with an SP-B deficiency presented within hours of birth with respiratory failure that required mechanical ventilation (20) . ABCA3 gene mutations have also been described in fatal respiratory diseases in newborns and severe chronic lung disease in infancy (21, 22) . In contrast, SFTPC mutations found in autosomal dominant diseases were often associated with ILD severities ranging from mild to severe and affected patients from the neonatal period (4) to adulthood (6). In the current study, a child presented with the symptoms, signs, and radiographic findings typical of ILD at the age of 5 mo and exhibited a history of persistent respiratory insufficiency for 9 y, indicating that SFTPC mutations were a possible contributor to her condition.
Immunohistochemical staining for proSP-C displayed abnormal distribution within secretory compartments in type II AECs of patient lung tissue specimens as compared with a control, indicating a potential association between proSP-C L55F and the alteration of subcellular proSP-C localization. This was supported by morphological alteration of type II AECs detected by TEM evaluation of lung tissue sections, which provided distinctive characterization by small and densely packed LBs with electron dense inclusions in type II AECs. , and proSP-C A116D in transfected A549 cells was performed to observe subcellular localization. The A549 cell line has been widely studied as a model for type II AECs to characterize the early steps of proSP-C maturation in vitro. Although A549 is a nonlamellar body cell line, when the wildtype isoform of proSP-C is transfected into A549 cells, proSP-C localizes to acidic, lysosomal-like organelles (23) . CD63/ LAMP3 is used to identify LBs, late endosomes, and lysosomes in type II AECs. Similarly to proSP-C
I73T
, proSP-C L55F also trafficked partially to CD63/LAMP3-positive vesicles, presumably for routing to the plasma membrane. Mutations located in the non-BRICHOS domain of proSP-C have been described as mistargeting proteins. Previous studies showed that proSP-C I73T was directed to plasma membrane and resulted in abnormal accumulation of the protein in endosome/lysosome compartments in vitro (11) . These data suggested that proSP-C L55F might be related to some extent to alterations in the subcellular localization of proSP-C I73T in A549 cells, although we could not confirm this result by western blotting. Ultrastructural images of proSP-C I73T with increased numbers of large, electron-dense vesicles containing organellar debris have demonstrated the disruption of degradation pathways through autophagy (24) . Therefore, the western blotting results, alterations in subcellular localization, and abnormally large electron-dense bodies in proSP-C L55F in our system might have been due in part to degradation pathway disruption by autophagic processes.
Consisting of a transmembrane and short extramembrane domain, the mature peptide of proSP-C is known to form a very rigid and stable α-helix (25). Valine is typically over-represented (>50% of amino acids) in the transmembrane domain of proSP-C. The hydrophobic peptides of SP-C and amyloid β-peptide are derived from the transmembrane region of their precursor protein with higher propensities for the β strand than helix conformation (26) . However, Congo red staining in this patient revealed no formation of amyloid-like deposits, which indicated that proSP-C L55F might not induce proSP-C misfolding and aggregation.
The main limitation of this study was that our A549 system corresponded to a homozygous rather than a heterozygous SFTPC mutation. To date, all known ILD-related SP-C mutations have been heterozygous, and thus a normal allele is also expressed in vivo situation (27) . Therefore, in previous multiple heterozygous expressions of mutant proteins associated with autosomal dominant diseases performed in vitro, cells coexpressing combinations of wild-type and mutant proteins were adopted to analyze the mechanism of genetic dominance of interfering mutations (9, 28) . Additional evaluations are required to establish the precise in vivo pathogenic mechanism of proSP-C L55F . In summary, we uncovered a new pathogenic mutation in SFTPC located in the mature domain of proSP-C in a Japanese girl with ILD. Functional analyses of transfected A549 cells expressing this mutant proSP-C L55F protein revealed that it may have caused altered subcellular localization. Further studies are needed for a more detailed understanding of the pathogenic mechanisms of genetic onset of this mutation.
METHODS
This study was approved by the institutional review board of the Shinshu University School of Medicine. Written informed consent was obtained from the patient's guardians and Japanese healthy volunteers.
Genetic Analyses
Genetic analyses were conducted on the patient from the age of 12 mo. Genomic DNA was extracted from peripheral blood samples of the patient, her parents, and 61 healthy control subjects using the QIAamp DNA blood mini kit (Qiagen GmbH, Hilden, Germany). The coding exons of SFTPC were amplified by PCR using previously described primers (29) . PCR products were confirmed by sequencing.
Immunohistochemistry of Lung Tissue
Lung tissue sections from the patient obtained by open lung biopsy at 5 mo of age were prepared from formalin-fixed paraffin-embedded samples. Control lung tissue was resected for malignancy. Immunohistochemistry was performed with antibodies against proSP-C, SP-B, ABCA3 (Abcam, Cambridge, UK), or proSP-B (Novocastra, Newcastle, UK), according to standard protocols (30) .
Congo Red Staining of Lung Tissue
Formalin-fixed paraffin-embedded lung tissue sections obtained by open chest biopsy at 5 mo of age were treated by Congo red solution and dehydrated using increasing concentrations of ethanol. The fluorescence signals were observed by polarization microscopy, and images were collected.
GFP/SP-C cDNA Constructs
To obtain wild-type human proSP-C (Met  1 to Ile   197 ), mRNA was extracted from sputum samples of healthy volunteers with the QIAamp RNA blood mini kit (Qiagen GmbH). cDNA fragments of SFTPC were amplified by the primer pairs A and D (Table 1) at the enzyme sites of BglII and EcoRI, respectively.
For mutant GFP/proSP-C
L55F
, the cDNA of wild-type human proSP-C served as the template using the primers by overlap extension PCR with a two-round, four-primer technique ( Table 1) . For construction of GFP/proSP-C I73T and GFP/proSP-C A116D , mutagenesis was also performed by overlap extension PCR, as described previously (9, 18, 31) . Following digestion with BglII at the 5' end and EcoRI at the 3' end, PCR products were purified for cloning into pAcGFP-C 1 vectors (Clontech, Mountain View, CA). These constructs were confirmed by sequencing. , or GFP/proSP-C A116D were generated for further analysis.
Generation of Stably
RNA Extraction and PCR of Stably Transfected A549 Cells
Total RNA was extracted from stably transfected A549 cells and reverse transcription to cDNA was performed using the PrimeScript RT reagent kit (TaKaRa Bio, Shiga, Japan). For semiquantitative RT-PCR, four 10-fold serial dilutions of template cDNAs from GFP/ proSP-C WT , GFP/proSP-C
L55F
, GFP/proSP-C
I73T
, or GFP/proSP-C A116D were amplified using primer pairs A and D (Table 1) and confirmed by sequencing. The amplification conditions of SFTPC and GAPDH were 1 cycle at 94 °C for 1 min, followed by 35 cycles of 94 °C for 30 s, 60 °C for 30 s, and 72 °C for 1 min.
Western Blotting
Stably transfected A549 cells were cultured for 12 h, harvested, and subjected to protein extraction. Western blotting was performed using primary antibodies, as follows: GFP (Clontech) at a 1:5,000 dilution and β-actin (MBL, Nagoya, Japan) at a 1:1,000 dilution. Peroxidase-labeled antibodies to mouse IgG and rabbit IgG (H+L; KPL, Gaithersburg, MD), respectively, were used as secondary antibodies. β-actin was used as the standard for normalizing protein samples. Detection was performed using an ECL system and target proteins were quantified using a densitometric image analyzer with NIH Image version 1.61 software (Bethesda, MD).
Fluorescence Microscopy
Stably transfectedA549 cells were cultured for 12 h on Lab-Tek II CC2 chamber slides (Thermo Fisher Scientific, Rochester, NY). The cells were fixed and incubated with primary antibodies for CD63/LAMP3 (BioLegend, San Diego, CA) or EEA1 (Cell Signaling Technology, Danvers, MA) at 1:100 dilutions. Species-specific Alexa Fluor 555-and 568-conjugated secondary antibodies (Invitrogen, Eugene, OR), respectively, were used at 1:500 dilutions. Samples were mounted using ProLong Gold Antifade Reagent with DAPI and examined using an LSM 5 EXCITER confocal laser scanning microscope (Carl Zeiss, Jena, Germany). Cells were also stained with ER-Tracker-Red (BODIPY TR, Glibenclamide, Invitrogen, Eugene, OR). 
